Gene · 84433
Papers2,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A new-disease-causing dominant-negative variant in CARD11 gene in a Chinese case with recurrent fever. | Sci Rep | 2024 | 39414811 | PubTator, text mining | PubMed |
| Transcriptome Profiling Associated with CARD11 Overexpression in Colorectal Cancer Implicates a Potential Role for Tumor Immune Microenvironment and Cancer Pathways Modulation via NF-κB. | Int J Mol Sci | 2024 | 39408697 | PubTator, text mining | PubMed |
| A20 intrinsically influences human effector T-cell survival and function by regulating both NF-κB and JNK signaling. | Eur J Immunol | 2024 | 39359035 | PubTator, text mining | PubMed |
| Specific Mutation Predict Relapse/Refractory Diffuse Large B-Cell Lymphoma. | J Blood Med | 2024 | 39279878 | PubTator, text mining | PubMed |
| [Histiocytic sarcoma derived from the same origin as splenic marginal zone lymphoma revealed by exome analysis]. | Rinsho Ketsueki | 2024 | 39231701 | PubTator, text mining | PubMed |
| Case report: ATM A1159T mutation in malignant peritoneal mesothelioma may be associated with tumor recurrence. | SAGE Open Med Case Rep | 2024 | 39161923 | PubTator, text mining | PubMed |
| Distinctive genomic features of human T-lymphotropic virus type 1-related adult T-cell leukemia-lymphoma in Western populations. | Haematologica | 2024 | 39113648 | PubTator, text mining | PubMed |
| B cells expressing mutated IGHV1-69-encoded antigen receptors related to virus neutralization show lymphoma-like transcriptomes in patients with chronic HCV infection. | Hepatol Commun | 2024 | 39082968 | PubTator, text mining | PubMed |
| A novel MALT1 variant in an Egyptian patient presenting with exfoliative dermatitis: a case-based review. | Immunol Res | 2024 | 39017781 | PubTator, text mining | PubMed |
| Engineered CARD11-PIK3R3 T-cell therapies as weapons of cancer mass destruction. | MedComm (2020) | 2024 | 38952574 | PubTator, text mining | PubMed |
| Genetic landscape of atopic dermatitis. | Curr Opin Allergy Clin Immunol | 2024 | 38920356 | PubTator, text mining | PubMed |
| Fluffy hybrid nanoadjuvants for reversing the imbalance of osteoclastic and osteogenic niches in osteoporosis. | Bioact Mater | 2024 | 38846529 | PubTator, text mining | PubMed |
| Rosace: a robust deep mutational scanning analysis framework employing position and mean-variance shrinkage. | Genome Biol | 2024 | 38789982 | PubTator, text mining | PubMed |
| Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma. | Leukemia | 2024 | 38750139 | PubTator, text mining | PubMed |
| The Molecular Landscape of Primary CNS Lymphomas (PCNSLs) in Children and Young Adults. | Cancers (Basel) | 2024 | 38730692 | PubTator, text mining | PubMed |
| Unveiling a novel fusion gene enhances CAR T cell therapy for solid tumors. | Mol Cancer | 2024 | 38730483 | PubTator, text mining | PubMed |
| Clinical characteristics, genetic alterations, and prognosis of adult T-cell leukemia/lymphoma: an 11-year multicenter retrospective study in China. | Am J Cancer Res | 2024 | 38726267 | PubTator, text mining | PubMed |
| Harnessing naturally occurring mutations for T-cell therapy: a potential new avenue to enhance treatment efficacy. | Signal Transduct Target Ther | 2024 | 38688914 | PubTator, text mining | PubMed |
| CARD11 regulates the thymic Treg development in an NF-κB-independent manner. | Front Immunol | 2024 | 38650932 | PubTator, text mining | PubMed |
| Somatic mutations in four novel genes contribute to homologous recombination deficiency in breast cancer: a real-world clinical tumor sequencing study. | J Pathol Clin Res | 2024 | 38504382 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84433/papers?page=6